Nuvectis Pharma, Inc. (NVCT)
NASDAQ: NVCT · Real-Time Price · USD
8.74
-0.30 (-3.32%)
At close: Feb 10, 2026, 4:00 PM EST
8.74
0.00 (0.00%)
After-hours: Feb 10, 2026, 4:04 PM EST
Nuvectis Pharma Market Cap
Nuvectis Pharma has a market cap or net worth of $223.87 million as of February 10, 2026. Its market cap has increased by 76.90% in one year.
Market Cap
223.87M
Enterprise Value
188.43M
1-Year Change
76.90%
Ranking
Category
Stock Price
$8.74
Market Cap Chart
Since the IPO on February 4, 2022, Nuvectis Pharma's market cap has increased from $58.01M to $223.87M, an increase of 285.95%. That is a compound annual growth rate of 39.97%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 9, 2026 | 231.56M | 19.74% |
| Dec 31, 2025 | 193.39M | 85.02% |
| Dec 31, 2024 | 104.53M | -27.67% |
| Dec 29, 2023 | 144.50M | 31.58% |
| Dec 30, 2022 | 109.82M | 89.32% |
| Feb 4, 2022 | 58.01M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Minerva Neurosciences | 244.50M |
| Humacyte | 235.46M |
| Cabaletta Bio | 234.89M |
| Heron Therapeutics | 234.70M |
| Opus Genetics | 233.10M |
| Achieve Life Sciences | 230.50M |
| MediWound | 230.14M |
| Inhibikase Therapeutics | 225.69M |